WSJ News Exclusive | DEA Investigating ADHD Telehealth Provider Done
U.S. Drug Enforcement Administration agents have questioned people about telehealth company Done Global Inc.’s practices for prescribing controlled substances, according...
Cerebral
WSJ News Exclusive | Mental-Health Startup Cerebral Investigated by FTC
The Federal Trade Commission has begun an investigation into mental-health startup Cerebral Inc., according to a letter the FTC sent...
Telehealth Startup Cerebral to Stop Prescribing Adderall for New Patients
Cerebral Inc. executives told its clinicians that the company will pause prescribing controlled substances such as Adderall to treat attention-deficit...
